Jevtana

cabazitaxel · Kit · Sanofi-Aventis U.S. LLC

NDC 00024-5824-11 · 1 KIT in 1 CARTON * 5.7 mL in 1 VIAL, GLASS * 5.7 mL in 1 VIAL, GLASS · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built

Data sources

CMS NADAC (pharmacy acquisition, weekly)
CMS Part B ASP quarterly payment limits
CMS Maximum Fair Prices (IRA negotiated, NDC-level)
Medicare Part D Spending by Drug (data.cms.gov, name-matched)
VA FSS / Big4 federal contract prices (va.gov, twice monthly)
ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
California SB-17 WAC filings (list price, per package)

Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Medicare Part B pays (ASP+6%)$233.73per billing unit (1 MG)HCPCS J9043 · Jul 1, 2026
Part D plans paid (avg)$9,013.03per dosage unitgross, before rebates — matched by drug name · 2024
Federal ceiling (Big4)$9,830.24per package of 1.5MLSanofi Aventis U.S. LLC · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$14,719.85

Reported to Texas DSHS · 2026 annual filing · Sanofi-Aventis US LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG

$233.730

HCPCS J9043 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$3.6M

613 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Sanofi Winthrop IndustrieFrance
analysis · api manufacture
Sanofi-Aventis Deutschland GmbHGermany
analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $14,546.69 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA201023
TE code: AP
Approval date: Jun 17, 2010
Patents / exclusivity: 10 patents, 0 exclusivities

Type	Number / code	Expires
patent	12453712*PED	Apr 27, 2031
patent	8927592*PED	Apr 27, 2031
patent	10583110*PED	Apr 27, 2031
patent	10716777*PED	Apr 27, 2031
patent	12453712	Oct 27, 2030
patent	10583110	Oct 27, 2030
patent	10716777	Oct 27, 2030
patent	8927592	Oct 27, 2030
patent	7241907*PED	Jun 10, 2026
patent	7241907	Dec 10, 2025

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of cabazitaxel (Kit)

Labeler	Strength	First seen	Last seen
Sanofi-Aventis U.S. LLC		Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Jevtana — NDC 00024-5824-11," retrieved September 3, 2026, https://drugdashboards.com/drug/00024582411.

Free to cite with attribution — see how the data is put together.